Merck invests in animal health tracking and monitoring with $2.4 billion acquisition of Antelliq

December 18, 2018
Emerging Ecosystems in Agrifood and Health More...
Very important

The acquisition comes after other players in the livestock health and production industry (e.g., Cargill) have strategically invested in animal health monitoring and tracking technology. Antelliq develops a wide array of animal health monitoring solutions for livestock, pet care, and aquaculture. Antelliq will be a wholly owned and separately operated subsidiary within Merck's animal health business unit. Antelliq provides Merck with a large client pool, which previously generated $360 million in annual revenue (while amassing $1.3 billion in debt). Even so, Antelliq's technologies complement Merck's health products, and therefore, clients should consider this a savvy move by Merck to strengthen its position in the animal health sector.

For the original news article, click here .

Further Reading

Cellular Agriculture

Technology | August 03, 2020

Production of cellular and acellular agricultural products from cell cultures; cellular products include clean meat, and acellular products include fermentation‑derived proteins and food ingredients. Not part of subscription

Merck Animal Health's acquisition of IdentiGEN indicates imminent system change for livestock production

News Commentary | August 06, 2020

IdentiGEN's DNA TraceBack combines livestock DNA and data analytics to increase the traceability of beef, seafood, pork, and poultry products. The deal closely follows Merck's acquisition of Quantified Ag and complements Merck's growing portfolio of animal health monitoring technologies. Moreover, ... To read more, click here.

Resilient Biotics' $7.1 million Series A highlights the value of applying bioinformatics with purpose

News Commentary | February 02, 2021

Co‑led by Berkeley Catalyst Fund and Fulcrum Global Capital, the round included participation from Elanco Animal Health, Innovation in Motion, and Viking Global Investors. Resilient Biotics develops a discovery platform to assess the respiratory commensal microbiome and identify potential ... Not part of subscription